☆ 4.7 Article Proceedings Paper

Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells

CANCER VACCINES (2009)

Related references

Note: Only part of the references are listed.

Article Immunology

Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo

Daniel J. Powell et al.

JOURNAL OF IMMUNOLOGY (2007)

Add to Collection

Article Immunology

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

UK Liyanage et al.

JOURNAL OF IMMUNOLOGY (2002)

Add to Collection

Article Immunology

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

EY Woo et al.

JOURNAL OF IMMUNOLOGY (2002)

Add to Collection

Article Immunology

Suppressor effector function of CD4(+)CD25(+) immunoregulatory T cells is antigen nonspecific

AM Thornton et al.

JOURNAL OF IMMUNOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.